Trials / Completed
CompletedNCT05362006
Exopulse Mollii Suit, Spasticity & Tissue Oxygenation
The Effects of a TENS System (Transcutaneous Electric Nerve Stimulation) on Spasticity and Muscular Oxygenation in Patients With Multiple Sclerosis (ENNOX Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Institut De La Colonne Vertebrale Et Des Neurosciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Spasticity is a frequent and debilitating symptom in patients with multiple sclerosis (MS). Sustained contractile activity, such as that observed in spastic muscles, could reduce the capillary density and induce important changes in the muscular microcirculation, leading to oxidative changes within the muscular tissue. Such changes reflect altered aerobic metabolism and impaired mitochondrial function. The available therapeutic strategies for treating spasticity and related symptoms are usually faced with limited efficacy and numerous side effects. For these reasons, non-invasive stimulation techniques, namely transcutaneous stimulation by means of Exopulse Mollii suit, might be of help in this context.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Exopulse Mollii Suit | Exopulse Mollii suit is a new assistive device that has been developed by Exoneural Network (initially Inerventions AB), a Swedish med-tech company. Exopulse Mollii suit is a full-body garment with integrated 58 electrodes that can transcutaneously stimulate 40 groups of muscles. This stimulation is not intended to obtain a motor effect (contraction of the muscles in question), but rather to decrease the spasticity in spastic muscles by activating the antagonistic muscles via the physiological mechanism of reciprocal inhibition. The device is CE labelled and is intended to use for reducing spasticity and improving blood circulation. The outfit is very easy to put on, it can be used for one hour every day and the analgesic effects last 24 hours or more. |
| DEVICE | Exopulse Mollii suit (sham) | In the sham condition, the control unit will be programmed to start stimulating for 1 minute then it will shut off. |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2023-04-18
- Completion
- 2023-05-30
- First posted
- 2022-05-05
- Last updated
- 2025-06-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05362006. Inclusion in this directory is not an endorsement.